nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—PTGS2—Nicotinamide salvaging—NAMPT—gestational diabetes	0.0327	0.0814	CbGpPWpGaD
Mesalazine—Hepatitis cholestatic—Glyburide—gestational diabetes	0.0281	0.0847	CcSEcCtD
Mesalazine—Nephropathy—Glyburide—gestational diabetes	0.0238	0.0716	CcSEcCtD
Mesalazine—IKBKB—embryo—gestational diabetes	0.0218	0.0817	CbGeAlD
Mesalazine—CHUK—adipose tissue—gestational diabetes	0.0211	0.0793	CbGeAlD
Mesalazine—ALOX5—islet of Langerhans—gestational diabetes	0.0187	0.07	CbGeAlD
Mesalazine—PTGS2—Nicotinate metabolism—NAMPT—gestational diabetes	0.0174	0.0433	CbGpPWpGaD
Mesalazine—CHUK—head—gestational diabetes	0.0162	0.0609	CbGeAlD
Mesalazine—Cholestasis—Glyburide—gestational diabetes	0.0149	0.0449	CcSEcCtD
Mesalazine—PPARG—Transcription factor regulation in adipogenesis—ADIPOQ—gestational diabetes	0.0147	0.0366	CbGpPWpGaD
Mesalazine—IKBKB—uterus—gestational diabetes	0.0147	0.0551	CbGeAlD
Mesalazine—IKBKB—adipose tissue—gestational diabetes	0.0144	0.0539	CbGeAlD
Mesalazine—PPARG—islet of Langerhans—gestational diabetes	0.014	0.0526	CbGeAlD
Mesalazine—PPARG—embryo—gestational diabetes	0.0135	0.0509	CbGeAlD
Mesalazine—PPARG—Differentiation of white and brown adipocyte   —ADIPOQ—gestational diabetes	0.0133	0.033	CbGpPWpGaD
Mesalazine—Jaundice cholestatic—Glyburide—gestational diabetes	0.0129	0.0388	CcSEcCtD
Mesalazine—IKBKB—Type II diabetes mellitus—ADIPOQ—gestational diabetes	0.0125	0.0312	CbGpPWpGaD
Mesalazine—IKBKB—vagina—gestational diabetes	0.0119	0.0448	CbGeAlD
Mesalazine—ALOX5—adipose tissue—gestational diabetes	0.0119	0.0447	CbGeAlD
Mesalazine—IKBKB—head—gestational diabetes	0.011	0.0414	CbGeAlD
Mesalazine—Aplastic anaemia—Glyburide—gestational diabetes	0.0106	0.032	CcSEcCtD
Mesalazine—Deafness—Glyburide—gestational diabetes	0.00919	0.0277	CcSEcCtD
Mesalazine—Hepatic failure—Glyburide—gestational diabetes	0.00915	0.0275	CcSEcCtD
Mesalazine—CHUK—Leptin signaling pathway—LEPR—gestational diabetes	0.00915	0.0228	CbGpPWpGaD
Mesalazine—ALOX5—head—gestational diabetes	0.00914	0.0343	CbGeAlD
Mesalazine—PPARG—uterus—gestational diabetes	0.00913	0.0343	CbGeAlD
Mesalazine—PPARG—Transcription factor regulation in adipogenesis—LEP—gestational diabetes	0.00913	0.0227	CbGpPWpGaD
Mesalazine—PPARG—Adipogenesis—RETN—gestational diabetes	0.00905	0.0225	CbGpPWpGaD
Mesalazine—PPARG—adipose tissue—gestational diabetes	0.00893	0.0335	CbGeAlD
Mesalazine—Renal failure acute—Glyburide—gestational diabetes	0.0089	0.0268	CcSEcCtD
Mesalazine—Renal impairment—Glyburide—gestational diabetes	0.00864	0.026	CcSEcCtD
Mesalazine—Dermatitis bullous—Glyburide—gestational diabetes	0.0086	0.0259	CcSEcCtD
Mesalazine—Arthritis—Glyburide—gestational diabetes	0.00846	0.0255	CcSEcCtD
Mesalazine—IKBKB—Leptin signaling pathway—LEPR—gestational diabetes	0.00829	0.0207	CbGpPWpGaD
Mesalazine—PPARG—Differentiation of white and brown adipocyte   —LEP—gestational diabetes	0.00824	0.0205	CbGpPWpGaD
Mesalazine—PPARG—Nuclear Receptors—AR—gestational diabetes	0.0082	0.0204	CbGpPWpGaD
Mesalazine—PPARG—SREBP signalling—RBP4—gestational diabetes	0.00802	0.02	CbGpPWpGaD
Mesalazine—MPO—head—gestational diabetes	0.00773	0.029	CbGeAlD
Mesalazine—PPARG—vagina—gestational diabetes	0.00743	0.0279	CbGeAlD
Mesalazine—PTGS2—islet of Langerhans—gestational diabetes	0.00716	0.0269	CbGeAlD
Mesalazine—Abdominal distension—Glyburide—gestational diabetes	0.00715	0.0215	CcSEcCtD
Mesalazine—Eosinophilia—Glyburide—gestational diabetes	0.00703	0.0212	CcSEcCtD
Mesalazine—Pancreatitis—Glyburide—gestational diabetes	0.00697	0.021	CcSEcCtD
Mesalazine—PTGS2—embryo—gestational diabetes	0.00692	0.026	CbGeAlD
Mesalazine—PPARG—head—gestational diabetes	0.00686	0.0258	CbGeAlD
Mesalazine—Pancytopenia—Glyburide—gestational diabetes	0.00675	0.0203	CcSEcCtD
Mesalazine—Photosensitivity reaction—Glyburide—gestational diabetes	0.00649	0.0195	CcSEcCtD
Mesalazine—PPARG—Nuclear Receptor transcription pathway—AR—gestational diabetes	0.00648	0.0161	CbGpPWpGaD
Mesalazine—Jaundice—Glyburide—gestational diabetes	0.00617	0.0186	CcSEcCtD
Mesalazine—Agranulocytosis—Glyburide—gestational diabetes	0.00591	0.0178	CcSEcCtD
Mesalazine—Hepatitis—Glyburide—gestational diabetes	0.00569	0.0171	CcSEcCtD
Mesalazine—PPARG—Transcriptional regulation of white adipocyte differentiation—ADIPOQ—gestational diabetes	0.00539	0.0134	CbGpPWpGaD
Mesalazine—Eye disorder—Glyburide—gestational diabetes	0.00531	0.016	CcSEcCtD
Mesalazine—PTGS1—Biological oxidations—GGCT—gestational diabetes	0.00507	0.0126	CbGpPWpGaD
Mesalazine—Alopecia—Glyburide—gestational diabetes	0.00503	0.0151	CcSEcCtD
Mesalazine—Erythema—Glyburide—gestational diabetes	0.00495	0.0149	CcSEcCtD
Mesalazine—PTGS1—uterus—gestational diabetes	0.00488	0.0183	CbGeAlD
Mesalazine—PTGS1—adipose tissue—gestational diabetes	0.00478	0.0179	CbGeAlD
Mesalazine—MPO—IL23-mediated signaling events—TNF—gestational diabetes	0.00477	0.0119	CbGpPWpGaD
Mesalazine—PTGS2—uterus—gestational diabetes	0.00467	0.0175	CbGeAlD
Mesalazine—Vision blurred—Glyburide—gestational diabetes	0.00467	0.014	CcSEcCtD
Mesalazine—Tremor—Glyburide—gestational diabetes	0.00464	0.014	CcSEcCtD
Mesalazine—Anaemia—Glyburide—gestational diabetes	0.00458	0.0138	CcSEcCtD
Mesalazine—PTGS2—adipose tissue—gestational diabetes	0.00457	0.0171	CbGeAlD
Mesalazine—Angioedema—Glyburide—gestational diabetes	0.00452	0.0136	CcSEcCtD
Mesalazine—Leukopenia—Glyburide—gestational diabetes	0.00443	0.0133	CcSEcCtD
Mesalazine—PPARG—Adipogenesis—NAMPT—gestational diabetes	0.00433	0.0108	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—MBL2—gestational diabetes	0.00427	0.0106	CbGpPWpGaD
Mesalazine—PPARG—Transcription factor regulation in adipogenesis—TNF—gestational diabetes	0.00422	0.0105	CbGpPWpGaD
Mesalazine—Arthralgia—Glyburide—gestational diabetes	0.00421	0.0127	CcSEcCtD
Mesalazine—Myalgia—Glyburide—gestational diabetes	0.00421	0.0127	CcSEcCtD
Mesalazine—Confusional state—Glyburide—gestational diabetes	0.00407	0.0123	CcSEcCtD
Mesalazine—Oedema—Glyburide—gestational diabetes	0.00404	0.0122	CcSEcCtD
Mesalazine—Shock—Glyburide—gestational diabetes	0.00398	0.012	CcSEcCtD
Mesalazine—PTGS1—vagina—gestational diabetes	0.00397	0.0149	CbGeAlD
Mesalazine—Nervous system disorder—Glyburide—gestational diabetes	0.00396	0.0119	CcSEcCtD
Mesalazine—Thrombocytopenia—Glyburide—gestational diabetes	0.00396	0.0119	CcSEcCtD
Mesalazine—Hyperhidrosis—Glyburide—gestational diabetes	0.00391	0.0118	CcSEcCtD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—MBL2—gestational diabetes	0.00387	0.00963	CbGpPWpGaD
Mesalazine—Anorexia—Glyburide—gestational diabetes	0.00385	0.0116	CcSEcCtD
Mesalazine—CHUK—EBV LMP1 signaling—TNF—gestational diabetes	0.00383	0.00953	CbGpPWpGaD
Mesalazine—CHUK—Canonical NF-kappaB pathway—TNF—gestational diabetes	0.00383	0.00953	CbGpPWpGaD
Mesalazine—PTGS2—vagina—gestational diabetes	0.0038	0.0142	CbGeAlD
Mesalazine—Hypotension—Glyburide—gestational diabetes	0.00378	0.0114	CcSEcCtD
Mesalazine—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—gestational diabetes	0.00369	0.0092	CbGpPWpGaD
Mesalazine—MPO—Vitamin B12 Metabolism—TNF—gestational diabetes	0.00369	0.00919	CbGpPWpGaD
Mesalazine—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.00368	0.0111	CcSEcCtD
Mesalazine—PTGS1—head—gestational diabetes	0.00367	0.0138	CbGeAlD
Mesalazine—Paraesthesia—Glyburide—gestational diabetes	0.00363	0.0109	CcSEcCtD
Mesalazine—Dyspnoea—Glyburide—gestational diabetes	0.0036	0.0108	CcSEcCtD
Mesalazine—IKBKB—Type II diabetes mellitus—TNF—gestational diabetes	0.00359	0.00895	CbGpPWpGaD
Mesalazine—Dyspepsia—Glyburide—gestational diabetes	0.00356	0.0107	CcSEcCtD
Mesalazine—PPARG—Adipogenesis—ADIPOQ—gestational diabetes	0.00355	0.00884	CbGpPWpGaD
Mesalazine—Decreased appetite—Glyburide—gestational diabetes	0.00351	0.0106	CcSEcCtD
Mesalazine—PTGS2—head—gestational diabetes	0.00351	0.0132	CbGeAlD
Mesalazine—PPARG—Circadian rythm related genes—MTNR1B—gestational diabetes	0.0035	0.00872	CbGpPWpGaD
Mesalazine—Gastrointestinal disorder—Glyburide—gestational diabetes	0.00349	0.0105	CcSEcCtD
Mesalazine—IKBKB—EBV LMP1 signaling—TNF—gestational diabetes	0.00347	0.00864	CbGpPWpGaD
Mesalazine—IKBKB—Canonical NF-kappaB pathway—TNF—gestational diabetes	0.00347	0.00864	CbGpPWpGaD
Mesalazine—PPARG—Transcriptional regulation of white adipocyte differentiation—LEP—gestational diabetes	0.00335	0.00834	CbGpPWpGaD
Mesalazine—Feeling abnormal—Glyburide—gestational diabetes	0.00333	0.01	CcSEcCtD
Mesalazine—PTGS1—Overview of nanoparticle effects—TNF—gestational diabetes	0.00333	0.00828	CbGpPWpGaD
Mesalazine—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—gestational diabetes	0.00332	0.00828	CbGpPWpGaD
Mesalazine—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.00332	0.00827	CbGpPWpGaD
Mesalazine—Gastrointestinal pain—Glyburide—gestational diabetes	0.0033	0.00995	CcSEcCtD
Mesalazine—CHUK—Leptin signaling pathway—LEP—gestational diabetes	0.00321	0.008	CbGpPWpGaD
Mesalazine—Urticaria—Glyburide—gestational diabetes	0.00321	0.00966	CcSEcCtD
Mesalazine—Abdominal pain—Glyburide—gestational diabetes	0.00319	0.00962	CcSEcCtD
Mesalazine—CHUK—Cardiac Hypertrophic Response—FGF2—gestational diabetes	0.00313	0.00779	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—NAMPT—gestational diabetes	0.00306	0.00762	CbGpPWpGaD
Mesalazine—MPO—Folate Metabolism—TNF—gestational diabetes	0.003	0.00747	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—GCK—gestational diabetes	0.00299	0.00744	CbGpPWpGaD
Mesalazine—Hypersensitivity—Glyburide—gestational diabetes	0.00298	0.00896	CcSEcCtD
Mesalazine—IKBKB—Leptin signaling pathway—LEP—gestational diabetes	0.00291	0.00725	CbGpPWpGaD
Mesalazine—Asthenia—Glyburide—gestational diabetes	0.0029	0.00873	CcSEcCtD
Mesalazine—CHUK—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—gestational diabetes	0.00287	0.00714	CbGpPWpGaD
Mesalazine—Pruritus—Glyburide—gestational diabetes	0.00286	0.00861	CcSEcCtD
Mesalazine—IKBKB—Cardiac Hypertrophic Response—FGF2—gestational diabetes	0.00284	0.00706	CbGpPWpGaD
Mesalazine—Diarrhoea—Glyburide—gestational diabetes	0.00276	0.00832	CcSEcCtD
Mesalazine—PTGS2—Overview of nanoparticle effects—TNF—gestational diabetes	0.00264	0.00658	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—CYP19A1—gestational diabetes	0.00262	0.00653	CbGpPWpGaD
Mesalazine—Vomiting—Glyburide—gestational diabetes	0.00257	0.00773	CcSEcCtD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—AR—gestational diabetes	0.00255	0.00636	CbGpPWpGaD
Mesalazine—Rash—Glyburide—gestational diabetes	0.00255	0.00767	CcSEcCtD
Mesalazine—Dermatitis—Glyburide—gestational diabetes	0.00255	0.00766	CcSEcCtD
Mesalazine—Headache—Glyburide—gestational diabetes	0.00253	0.00762	CcSEcCtD
Mesalazine—PPARG—Circadian rythm related genes—ADIPOQ—gestational diabetes	0.0025	0.00623	CbGpPWpGaD
Mesalazine—Nausea—Glyburide—gestational diabetes	0.0024	0.00723	CcSEcCtD
Mesalazine—MPO—Selenium Micronutrient Network—TNF—gestational diabetes	0.00238	0.00594	CbGpPWpGaD
Mesalazine—CHUK—TWEAK Signaling Pathway—TNF—gestational diabetes	0.00236	0.00588	CbGpPWpGaD
Mesalazine—ALOX5—Selenium Micronutrient Network—TNF—gestational diabetes	0.00225	0.0056	CbGpPWpGaD
Mesalazine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—FGF2—gestational diabetes	0.00223	0.00555	CbGpPWpGaD
Mesalazine—PPARG—Adipogenesis—LEP—gestational diabetes	0.0022	0.00549	CbGpPWpGaD
Mesalazine—CHUK—TNF receptor signaling pathway —TNF—gestational diabetes	0.0022	0.00547	CbGpPWpGaD
Mesalazine—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—gestational diabetes	0.00219	0.00545	CbGpPWpGaD
Mesalazine—CHUK—Constitutive PI3K/AKT Signaling in Cancer—FGF2—gestational diabetes	0.00219	0.00545	CbGpPWpGaD
Mesalazine—IKBKB—TWEAK Signaling Pathway—TNF—gestational diabetes	0.00214	0.00534	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.00211	0.00527	CbGpPWpGaD
Mesalazine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—FGF2—gestational diabetes	0.00202	0.00503	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—GGCT—gestational diabetes	0.002	0.00498	CbGpPWpGaD
Mesalazine—IKBKB—TNF receptor signaling pathway —TNF—gestational diabetes	0.00199	0.00496	CbGpPWpGaD
Mesalazine—CHUK—PI-3K cascade—FGF2—gestational diabetes	0.00197	0.00491	CbGpPWpGaD
Mesalazine—CHUK—PI3K/AKT activation—FGF2—gestational diabetes	0.00192	0.00479	CbGpPWpGaD
Mesalazine—CHUK—GAB1 signalosome—FGF2—gestational diabetes	0.00191	0.00475	CbGpPWpGaD
Mesalazine—CHUK—Cardiac Hypertrophic Response—TNF—gestational diabetes	0.0019	0.00474	CbGpPWpGaD
Mesalazine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—FGF2—gestational diabetes	0.00186	0.00464	CbGpPWpGaD
Mesalazine—PTGS1—Biological oxidations—CYP19A1—gestational diabetes	0.00176	0.00439	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—GLS2—gestational diabetes	0.00175	0.00435	CbGpPWpGaD
Mesalazine—IKBKB—Cardiac Hypertrophic Response—TNF—gestational diabetes	0.00173	0.0043	CbGpPWpGaD
Mesalazine—PPARG—Signaling events mediated by HDAC Class I—TNF—gestational diabetes	0.00167	0.00417	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.00156	0.00389	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—LEP—gestational diabetes	0.00155	0.00387	CbGpPWpGaD
Mesalazine—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—gestational diabetes	0.00155	0.00386	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—GCK—gestational diabetes	0.00148	0.00369	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—FGF2—gestational diabetes	0.00147	0.00367	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.00141	0.00351	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—FGF2—gestational diabetes	0.00139	0.00345	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—MBL2—gestational diabetes	0.00137	0.0034	CbGpPWpGaD
Mesalazine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TNF—gestational diabetes	0.00136	0.00338	CbGpPWpGaD
Mesalazine—CHUK—Apoptosis—TNF—gestational diabetes	0.00136	0.00338	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—FGF2—gestational diabetes	0.00132	0.0033	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—LEP—gestational diabetes	0.00132	0.0033	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—FGF2—gestational diabetes	0.00132	0.00328	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—FGF2—gestational diabetes	0.00131	0.00327	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—FGF2—gestational diabetes	0.0013	0.00325	CbGpPWpGaD
Mesalazine—PTGS2—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.0013	0.00324	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.00129	0.0032	CbGpPWpGaD
Mesalazine—CHUK—TNF alpha Signaling Pathway—TNF—gestational diabetes	0.00126	0.00314	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.00125	0.00312	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—MBL2—gestational diabetes	0.00124	0.00308	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GGCT—gestational diabetes	0.00124	0.00308	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis—TNF—gestational diabetes	0.00123	0.00306	CbGpPWpGaD
Mesalazine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—gestational diabetes	0.00123	0.00306	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—FGF2—gestational diabetes	0.00123	0.00306	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—FGF2—gestational diabetes	0.00123	0.00306	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.00123	0.00306	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—ADIPOQ—gestational diabetes	0.00122	0.00304	CbGpPWpGaD
Mesalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—gestational diabetes	0.00122	0.00303	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—FGF2—gestational diabetes	0.00122	0.00303	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.00121	0.003	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—FGF2—gestational diabetes	0.0012	0.00299	CbGpPWpGaD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.00117	0.0029	CbGpPWpGaD
Mesalazine—CHUK—Toll-like Receptor Signaling Pathway—TNF—gestational diabetes	0.00116	0.00289	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.00116	0.00288	CbGpPWpGaD
Mesalazine—IKBKB—TNF alpha Signaling Pathway—TNF—gestational diabetes	0.00114	0.00285	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—FGF2—gestational diabetes	0.00114	0.00283	CbGpPWpGaD
Mesalazine—PPARG—Generic Transcription Pathway—AR—gestational diabetes	0.00112	0.00279	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.00111	0.00277	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.00109	0.00271	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GLS2—gestational diabetes	0.00108	0.00269	CbGpPWpGaD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—TNF—gestational diabetes	0.00105	0.00262	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—FGF2—gestational diabetes	0.00103	0.00257	CbGpPWpGaD
Mesalazine—PPARG—Adipogenesis—TNF—gestational diabetes	0.00102	0.00254	CbGpPWpGaD
Mesalazine—PTGS1—Selenium Micronutrient Network—TNF—gestational diabetes	0.000976	0.00243	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000967	0.00241	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—NAMPT—gestational diabetes	0.000957	0.00238	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—GCK—gestational diabetes	0.000951	0.00237	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—TNF—gestational diabetes	0.000907	0.00226	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GGCT—gestational diabetes	0.000867	0.00216	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—FGF2—gestational diabetes	0.000836	0.00208	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—gestational diabetes	0.000822	0.00205	CbGpPWpGaD
Mesalazine—CHUK—Immune System—MBL2—gestational diabetes	0.000796	0.00198	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—TNF—gestational diabetes	0.000774	0.00193	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—FGF2—gestational diabetes	0.000758	0.00189	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GLS2—gestational diabetes	0.000758	0.00189	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—LEP—gestational diabetes	0.000757	0.00189	CbGpPWpGaD
Mesalazine—CHUK—Disease—RBP4—gestational diabetes	0.000741	0.00184	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—MBL2—gestational diabetes	0.000721	0.0018	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TNF—gestational diabetes	0.000707	0.00176	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000703	0.00175	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—CYP19A1—gestational diabetes	0.000696	0.00173	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GGCT—gestational diabetes	0.000688	0.00171	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000684	0.0017	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000677	0.00169	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—LEPR—gestational diabetes	0.000673	0.00168	CbGpPWpGaD
Mesalazine—CHUK—Disease—NAMPT—gestational diabetes	0.000664	0.00165	CbGpPWpGaD
Mesalazine—CHUK—Disease—GCK—gestational diabetes	0.00066	0.00164	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TNF—gestational diabetes	0.000612	0.00153	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—LEPR—gestational diabetes	0.00061	0.00152	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GLS2—gestational diabetes	0.000601	0.0015	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—NAMPT—gestational diabetes	0.000593	0.00148	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GCK—gestational diabetes	0.000589	0.00147	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—FGF2—gestational diabetes	0.000575	0.00143	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—AR—gestational diabetes	0.000539	0.00134	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000538	0.00134	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MTNR1B—gestational diabetes	0.000532	0.00133	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—RBP4—gestational diabetes	0.000519	0.00129	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MTNR1B—gestational diabetes	0.000483	0.0012	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—FGF2—gestational diabetes	0.000477	0.00119	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—RBP4—gestational diabetes	0.00047	0.00117	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—FGF2—gestational diabetes	0.000458	0.00114	CbGpPWpGaD
Mesalazine—PTGS2—Disease—RBP4—gestational diabetes	0.000439	0.00109	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—FGF2—gestational diabetes	0.000433	0.00108	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—CYP19A1—gestational diabetes	0.000431	0.00107	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000417	0.00104	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—FGF2—gestational diabetes	0.000415	0.00103	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—NAMPT—gestational diabetes	0.000415	0.00103	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GCK—gestational diabetes	0.000412	0.00103	CbGpPWpGaD
Mesalazine—PTGS2—Disease—NAMPT—gestational diabetes	0.000393	0.00098	CbGpPWpGaD
Mesalazine—PTGS2—Disease—GCK—gestational diabetes	0.000391	0.000974	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TNF—gestational diabetes	0.00035	0.000873	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—NAMPT—gestational diabetes	0.00033	0.000821	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GCK—gestational diabetes	0.000327	0.000816	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CYP19A1—gestational diabetes	0.000302	0.000751	CbGpPWpGaD
Mesalazine—CHUK—Immune System—FGF2—gestational diabetes	0.000278	0.000692	CbGpPWpGaD
Mesalazine—CHUK—Disease—FGF2—gestational diabetes	0.000256	0.000639	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—FGF2—gestational diabetes	0.000252	0.000627	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CYP19A1—gestational diabetes	0.000239	0.000596	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—LEP—gestational diabetes	0.000236	0.000589	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—LEP—gestational diabetes	0.000214	0.000534	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—FGF2—gestational diabetes	0.00018	0.000447	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—FGF2—gestational diabetes	0.000163	0.000406	CbGpPWpGaD
Mesalazine—PTGS2—Disease—FGF2—gestational diabetes	0.000152	0.000378	CbGpPWpGaD
